华东医药等新设股权投资合伙企业，出资额20亿

Group 1 - The establishment of Hangzhou Fuguang Hongze Equity Investment Partnership (Limited Partnership) with a capital contribution of 2 billion is reported [1] - The business scope of the new partnership includes equity investment and venture capital, specifically limited to investing in unlisted companies [1] - East China Pharmaceutical (000963) is among the contributors to this new investment partnership [1]